“…The strengths of this study are its prospective approach, the well-established study protocol, 8,9,17 and the use of one product brand, which allowed us to eliminate technical factors that could bias the evaluation. Furthermore, two different orthopedic surgeons determined the indication for LIPUS therapy and analyzed the data, which also minimized bias.…”